Related Experiment Video

Updated: Nov 8, 2025

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.6K

Challenges in the recognition and management of paediatric sepsis - The journey

Amanda Harley1, Luregn J Schlapbach2, Amy N B Johnston3

  • 1School of Nursing, Midwifery and Social Work, The University of Queensland, Brisbane, QLD, Australia; Child Health Research Centre, The University of Queensland, and Paediatric Intensive Care Unit, Queensland Children's Hospital, Brisbane, QLD, Australia; Department of Emergency Medicine, Gold Coast University Hospital, Gold Coast, QLD, Australia.

Australasian Emergency Care
|April 18, 2021
PubMed

Insights

Paediatric sepsis is a major cause of childhood death and disability. A unified approach is needed, emphasizing families, pre-hospital care, and multidisciplinary post-sepsis support for better outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Public health policy
  • Emergency medicine

Background:

  • Paediatric sepsis is a significant cause of mortality and long-term morbidity in children.
  • Current guidelines focus on in-hospital management, with less emphasis on pre-hospital and post-sepsis care.
  • A unified, holistic approach is essential for improving outcomes.

Purpose of the Study:

  • To critically discuss challenges in paediatric sepsis care.
  • To highlight the importance of family, pre-hospital, and multidisciplinary post-sepsis care.
  • To inform future healthcare delivery and research in paediatric sepsis.

Main Methods:

  • Literature review of contemporary research on paediatric sepsis.
  • Critical discussion of key challenges in recognition and management.
  • Analysis of the patient journey from pre-hospital to post-sepsis care.

Main Results:

  • Paediatric sepsis requires a broader focus beyond hospital settings.
  • The roles of families, paramedics, and nurses in early recognition are crucial but under-represented.
  • Multidisciplinary, patient-centred care is vital for managing sequelae.

Conclusions:

  • Enhanced recognition and management strategies for paediatric sepsis are needed.
  • Integrating families and pre-hospital care into sepsis protocols is paramount.
  • Further research into holistic, patient-centred paediatric sepsis care is essential.

Keywords:
CommunityEmergency nurseGuidelineLong-term outcomePaediatricSepsis

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.4K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.2K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
64
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
557
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
72
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
71
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
101
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
90